APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Consumer Healthcare Drug

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Consumer Healthcare Drug Industry Growth and Trends Forecast to 2032

Report ID 173980680120 December 2025113 pages

Choose your research edition.

Industry ResearchConsumer Healthcare Drug Industry Research Report 2026134 pages · $2,950 USDIndustry Growth & TrendsGlobal Consumer Healthcare Drug Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Consumer Healthcare Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Consumer Healthcare Drug Market Outlook and Growth Opportunities 2026201 pages · $4,250 USDMarket Analysis & ForecastGlobal Consumer Healthcare Drug Market Analysis and Forecast 2026-2032205 pages · $4,950 USD

Market perspective

According to APO Research, the global Consumer Healthcare Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Consumer Healthcare Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Consumer Healthcare Drug is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Consumer Healthcare Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Consumer Healthcare Drug market include Takeda, Teva, Shanghai Pharmaceuticals, Sanofi, Johnson & Johnson, Merck & Co., Pfizer, Hualan Bio and North China Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Consumer Healthcare Drug market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Consumer Healthcare Drug market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Consumer Healthcare Drug market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Consumer Healthcare Drug.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Consumer Healthcare Drug market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Consumer Healthcare Drug Market by Company

Takeda

Teva

Shanghai Pharmaceuticals

Sanofi

Johnson & Johnson

Merck & Co.

Pfizer

Hualan Bio

North China Pharmaceutical

Hengrui Medicine

GlaxoSmithKline

Bayer

AbbVie

Sinopharm Group

Livzon Group

Fosun Pharma

East China Medicine

CR Pharmaceutical

Consumer Healthcare Drug Segment by Type

Patch

Oral Liquid

Solid Preparations

Other

Consumer Healthcare Drug Segment by Application

Hospital

Retail Pharmacy

Other

Consumer Healthcare Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Consumer Healthcare Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Consumer Healthcare Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Consumer Healthcare Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Consumer Healthcare Drug companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Consumer Healthcare Drug Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Consumer Healthcare Drug Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Consumer Healthcare Drug Market Share by Region (2021-2026) Table 4. Global Consumer Healthcare Drug Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Consumer Healthcare Drug Market Share by Region (2027-2032) Table 6. Global Consumer Healthcare Drug Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Consumer Healthcare Drug Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Consumer Healthcare Drug Market Size Share by Type (2021-2026) Table 9. Global Consumer Healthcare Drug Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Consumer Healthcare Drug Market Size Share Forecasted by Type (2027-2032) Table 11. North America Consumer Healthcare Drug Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Consumer Healthcare Drug Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Consumer Healthcare Drug Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Consumer Healthcare Drug Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Consumer Healthcare Drug Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Consumer Healthcare Drug Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Consumer Healthcare Drug Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Consumer Healthcare Drug Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Consumer Healthcare Drug Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Consumer Healthcare Drug Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Consumer Healthcare Drug Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Consumer Healthcare Drug Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Consumer Healthcare Drug Market Size Share by Application (2021-2026) Table 24. Global Consumer Healthcare Drug Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Consumer Healthcare Drug Market Size Share Forecasted by Application (2027-2032) Table 26. North America Consumer Healthcare Drug Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Consumer Healthcare Drug Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Consumer Healthcare Drug Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Consumer Healthcare Drug Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Consumer Healthcare Drug Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Consumer Healthcare Drug Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Consumer Healthcare Drug Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Consumer Healthcare Drug Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Consumer Healthcare Drug Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Consumer Healthcare Drug Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Consumer Healthcare Drug Industry Trends Table 37. Consumer Healthcare Drug Industry Drivers Table 38. Consumer Healthcare Drug Industry Opportunities and Challenges Table 39. Consumer Healthcare Drug Industry Restraints Table 40. Global Consumer Healthcare Drug Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Consumer Healthcare Drug Revenue Market Share by Company (2021-2026) Table 42. Global Consumer Healthcare Drug Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Consumer Healthcare Drug Key Company Headquarters & Area Served Table 44. Global Consumer Healthcare Drug Company, Product Type & Application Table 45. Global Consumer Healthcare Drug Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Consumer Healthcare Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Takeda Company Information Table 49. Takeda Business Overview Table 50. Takeda Consumer Healthcare Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Takeda Consumer Healthcare Drug Product Portfolio Table 52. Takeda Recent Development Table 53. Teva Company Information Table 54. Teva Business Overview Table 55. Teva Consumer Healthcare Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Teva Consumer Healthcare Drug Product Portfolio Table 57. Teva Recent Development Table 58. Shanghai Pharmaceuticals Company Information Table 59. Shanghai Pharmaceuticals Business Overview Table 60. Shanghai Pharmaceuticals Consumer Healthcare Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Shanghai Pharmaceuticals Consumer Healthcare Drug Product Portfolio Table 62. Shanghai Pharmaceuticals Recent Development Table 63. Sanofi Company Information Table 64. Sanofi Business Overview Table 65. Sanofi Consumer Healthcare Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Sanofi Consumer Healthcare Drug Product Portfolio Table 67. Sanofi Recent Development Table 68. Johnson & Johnson Company Information Table 69. Johnson & Johnson Business Overview Table 70. Johnson & Johnson Consumer Healthcare Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Johnson & Johnson Consumer Healthcare Drug Product Portfolio Table 72. Johnson & Johnson Recent Development Table 73. Merck & Co. Company Information Table 74. Merck & Co. Business Overview Table 75. Merck & Co. Consumer Healthcare Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Merck & Co. Consumer Healthcare Drug Product Portfolio Table 77. Merck & Co. Recent Development Table 78. Pfizer Company Information Table 79. Pfizer Business Overview Table 80. Pfizer Consumer Healthcare Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Pfizer Consumer Healthcare Drug Product Portfolio Table 82. Pfizer Recent Development Table 83. Hualan Bio Company Information Table 84. Hualan Bio Business Overview Table 85. Hualan Bio Consumer Healthcare Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Hualan Bio Consumer Healthcare Drug Product Portfolio Table 87. Hualan Bio Recent Development Table 88. North China Pharmaceutical Company Information Table 89. North China Pharmaceutical Business Overview Table 90. North China Pharmaceutical Consumer Healthcare Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. North China Pharmaceutical Consumer Healthcare Drug Product Portfolio Table 92. North China Pharmaceutical Recent Development Table 93. Hengrui Medicine Company Information Table 94. Hengrui Medicine Business Overview Table 95. Hengrui Medicine Consumer Healthcare Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Hengrui Medicine Consumer Healthcare Drug Product Portfolio Table 97. Hengrui Medicine Recent Development Table 98. GlaxoSmithKline Company Information Table 99. GlaxoSmithKline Business Overview Table 100. GlaxoSmithKline Consumer Healthcare Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. GlaxoSmithKline Consumer Healthcare Drug Product Portfolio Table 102. GlaxoSmithKline Recent Development Table 103. Bayer Company Information Table 104. Bayer Business Overview Table 105. Bayer Consumer Healthcare Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Bayer Consumer Healthcare Drug Product Portfolio Table 107. Bayer Recent Development Table 108. AbbVie Company Information Table 109. AbbVie Business Overview Table 110. AbbVie Consumer Healthcare Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. AbbVie Consumer Healthcare Drug Product Portfolio Table 112. AbbVie Recent Development Table 113. Sinopharm Group Company Information Table 114. Sinopharm Group Business Overview Table 115. Sinopharm Group Consumer Healthcare Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Sinopharm Group Consumer Healthcare Drug Product Portfolio Table 117. Sinopharm Group Recent Development Table 118. Livzon Group Company Information Table 119. Livzon Group Business Overview Table 120. Livzon Group Consumer Healthcare Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. Livzon Group Consumer Healthcare Drug Product Portfolio Table 122. Livzon Group Recent Development Table 123. Fosun Pharma Company Information Table 124. Fosun Pharma Business Overview Table 125. Fosun Pharma Consumer Healthcare Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. Fosun Pharma Consumer Healthcare Drug Product Portfolio Table 127. Fosun Pharma Recent Development Table 128. East China Medicine Company Information Table 129. East China Medicine Business Overview Table 130. East China Medicine Consumer Healthcare Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 131. East China Medicine Consumer Healthcare Drug Product Portfolio Table 132. East China Medicine Recent Development Table 133. CR Pharmaceutical Company Information Table 134. CR Pharmaceutical Business Overview Table 135. CR Pharmaceutical Consumer Healthcare Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 136. CR Pharmaceutical Consumer Healthcare Drug Product Portfolio Table 137. CR Pharmaceutical Recent Development Table 138. North America Consumer Healthcare Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. North America Consumer Healthcare Drug Market Size by Country (2021-2026) & (US$ Million) Table 140. North America Consumer Healthcare Drug Market Share by Country (2021-2026) Table 141. North America Consumer Healthcare Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. North America Consumer Healthcare Drug Market Share Forecast by Country (2027-2032) Table 143. Europe Consumer Healthcare Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Europe Consumer Healthcare Drug Market Size by Country (2021-2026) & (US$ Million) Table 145. Europe Consumer Healthcare Drug Market Share by Country (2021-2026) Table 146. Europe Consumer Healthcare Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Europe Consumer Healthcare Drug Market Share Forecast by Country (2027-2032) Table 148. Asia-Pacific Consumer Healthcare Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Asia-Pacific Consumer Healthcare Drug Market Size by Country (2021-2026) & (US$ Million) Table 150. Asia-Pacific Consumer Healthcare Drug Market Share by Country (2021-2026) Table 151. Asia-Pacific Consumer Healthcare Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Asia-Pacific Consumer Healthcare Drug Market Share Forecast by Country (2027-2032) Table 153. Latin America Consumer Healthcare Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. Latin America Consumer Healthcare Drug Market Size by Country (2021-2026) & (US$ Million) Table 155. Latin America Consumer Healthcare Drug Market Share by Country (2021-2026) Table 156. Latin America Consumer Healthcare Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. Latin America Consumer Healthcare Drug Market Share Forecast by Country (2027-2032) Table 158. Middle East & Africa Consumer Healthcare Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. Middle East & Africa Consumer Healthcare Drug Market Size by Country (2021-2026) & (US$ Million) Table 160. Middle East & Africa Consumer Healthcare Drug Market Share by Country (2021-2026) Table 161. Middle East & Africa Consumer Healthcare Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. Middle East & Africa Consumer Healthcare Drug Market Share Forecast by Country (2027-2032) Table 163. Research Programs/Design for This Report Table 164. Authors List of This Report Table 165. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Consumer Healthcare Drug Product Image Figure 3. Global Consumer Healthcare Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Consumer Healthcare Drug Market Size (2021-2032) & (US$ Million) Figure 5. Global Consumer Healthcare Drug Market Share by Region: 2025 VS 2032 Figure 6. Global Consumer Healthcare Drug Market Share by Region (2021-2032) Figure 7. North America Consumer Healthcare Drug Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Consumer Healthcare Drug Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Consumer Healthcare Drug Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Consumer Healthcare Drug Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Consumer Healthcare Drug Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Patch Image Figure 13. Global Patch Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Oral Liquid Image Figure 15. Global Oral Liquid Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Solid Preparations Image Figure 17. Global Solid Preparations Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Other Image Figure 19. Global Other Market Size YoY Growth (2021-2032) & (US$ Million) Figure 20. Global Consumer Healthcare Drug Market Size Overview by Type (2021-2032) & (US$ Million) Figure 21. Global Consumer Healthcare Drug Market Share by Type 2025 VS 2032 Figure 22. North America Consumer Healthcare Drug Market Size Share by Type (2021-2032) Figure 23. Europe Consumer Healthcare Drug Market Size Share by Type (2021-2032) Figure 24. Asia-Pacific Consumer Healthcare Drug Market Size Share by Type (2021-2032) Figure 25. Latin America Consumer Healthcare Drug Market Size Share by Type (2021-2032) Figure 26. Middle East and Africa Consumer Healthcare Drug Market Size Share by Type (2021-2032) Figure 27. Hospital Image Figure 28. Global Hospital Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Retail Pharmacy Image Figure 30. Global Retail Pharmacy Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Other Image Figure 32. Global Other Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Global Consumer Healthcare Drug Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Consumer Healthcare Drug Market Share by Application 2025 VS 2032 Figure 35. North America Consumer Healthcare Drug Market Size Share by Application (2021-2032) Figure 36. Europe Consumer Healthcare Drug Market Size Share by Application (2021-2032) Figure 37. Asia-Pacific Consumer Healthcare Drug Market Size Share by Application (2021-2032) Figure 38. Latin America Consumer Healthcare Drug Market Size Share by Application (2021-2032) Figure 39. Middle East and Africa Consumer Healthcare Drug Market Size Share by Application (2021-2032) Figure 40. Global Top 5 and 10 Consumer Healthcare Drug Players Market Share by Revenue in 2025 Figure 41. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 42. North America Consumer Healthcare Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 43. North America Consumer Healthcare Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 44. North America Consumer Healthcare Drug Market Share by Country (2021-2032) Figure 45. Europe Consumer Healthcare Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Consumer Healthcare Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Consumer Healthcare Drug Market Share by Country (2021-2032) Figure 48. Asia-Pacific Consumer Healthcare Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 49. Asia-Pacific Consumer Healthcare Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 50. Asia-Pacific Consumer Healthcare Drug Market Share by Country (2021-2032) Figure 51. Latin America Consumer Healthcare Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Latin America Consumer Healthcare Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Consumer Healthcare Drug Market Share by Country (2021-2032) Figure 54. Middle East & Africa Consumer Healthcare Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Middle East & Africa Consumer Healthcare Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 56. Middle East & Africa Consumer Healthcare Drug Market Share by Country (2021-2032) Figure 57. Years Considered Figure 58. Research Process Figure 59. Key Executives Interviewed

Scope & coverage.

Types
  • Patch
  • Oral Liquid
  • Solid Preparations
  • Other
Applications
  • Hospital
  • Retail Pharmacy
  • Other
Companies covered
  • Takeda
  • Teva
  • Shanghai Pharmaceuticals
  • Sanofi
  • Johnson & Johnson
  • Merck & Co.
  • Pfizer
  • Hualan Bio
  • North China Pharmaceutical
  • Hengrui Medicine
  • GlaxoSmithKline
  • Bayer
  • AbbVie
  • Sinopharm Group
  • Livzon Group
  • Fosun Pharma
  • East China Medicine
  • CR Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Consumer Healthcare Drug Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Consumer Healthcare Drug Market Size by Region (2021-2032)
  5. 1.4.1 Global Consumer Healthcare Drug Market Size by Region (2021-2026)
  6. 1.4.2 Global Consumer Healthcare Drug Market Size by Region (2027-2032)
  7. 1.5 Key Regions Consumer Healthcare Drug Market Size (2021-2032)
  8. 1.5.1 North America Consumer Healthcare Drug Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Consumer Healthcare Drug Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Consumer Healthcare Drug Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Consumer Healthcare Drug Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Consumer Healthcare Drug Market Size Growth Rate (2021-2032)
2 Consumer Healthcare Drug Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Patch
  3. 2.1.2 Oral Liquid
  4. 2.1.3 Solid Preparations
  5. 2.1.4 Other
  6. 2.2 Global Consumer Healthcare Drug Market Size by Type
  7. 2.2.1 Global Consumer Healthcare Drug Market Size Overview by Type (2021-2032)
  8. 2.2.2 Global Consumer Healthcare Drug Historic Market Size Review by Type (2021-2026)
  9. 2.2.3 Global Consumer Healthcare Drug Market Size Forecasted by Type (2027-2032)
  10. 2.3 Global Consumer Healthcare Drug Market Size by Regions
  11. 2.3.1 North America Consumer Healthcare Drug Market Size Breakdown by Type (2021-2026)
  12. 2.3.2 Europe Consumer Healthcare Drug Market Size Breakdown by Type (2021-2026)
  13. 2.3.3 Asia-Pacific Consumer Healthcare Drug Market Size Breakdown by Type (2021-2026)
  14. 2.3.4 South America Consumer Healthcare Drug Market Size Breakdown by Type (2021-2026)
  15. 2.3.5 Middle East and Africa Consumer Healthcare Drug Market Size Breakdown by Type (2021-2026)
3 Consumer Healthcare Drug Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Hospital
  3. 3.1.2 Retail Pharmacy
  4. 3.1.3 Other
  5. 3.2 Global Consumer Healthcare Drug Market Size by Application
  6. 3.2.1 Global Consumer Healthcare Drug Market Size Overview by Application (2021-2032)
  7. 3.2.2 Global Consumer Healthcare Drug Historic Market Size Review by Application (2021-2026)
  8. 3.2.3 Global Consumer Healthcare Drug Market Size Forecasted by Application (2027-2032)
  9. 3.3 Global Consumer Healthcare Drug Market Size by Regions
  10. 3.3.1 North America Consumer Healthcare Drug Market Size Breakdown by Application (2021-2026)
  11. 3.3.2 Europe Consumer Healthcare Drug Market Size Breakdown by Application (2021-2026)
  12. 3.3.3 Asia-Pacific Consumer Healthcare Drug Market Size Breakdown by Application (2021-2026)
  13. 3.3.4 South America Consumer Healthcare Drug Market Size Breakdown by Application (2021-2026)
  14. 3.3.5 Middle East and Africa Consumer Healthcare Drug Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Consumer Healthcare Drug Industry Trends
  2. 4.2 Consumer Healthcare Drug Industry Drivers
  3. 4.3 Consumer Healthcare Drug Industry Opportunities and Challenges
  4. 4.4 Consumer Healthcare Drug Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Consumer Healthcare Drug Revenue (2021-2026)
  2. 5.2 Global Consumer Healthcare Drug Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Consumer Healthcare Drug Key Company Headquarters & Area Served
  4. 5.4 Global Consumer Healthcare Drug Company, Product Type & Application
  5. 5.5 Global Consumer Healthcare Drug Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Consumer Healthcare Drug Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Consumer Healthcare Drug Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Consumer Healthcare Drug Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Takeda
  2. 6.1.1 Takeda Company Information
  3. 6.1.2 Takeda Business Overview
  4. 6.1.3 Takeda Consumer Healthcare Drug Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Takeda Consumer Healthcare Drug Product Portfolio
  6. 6.1.5 Takeda Recent Developments
  7. 6.2 Teva
  8. 6.2.1 Teva Company Information
  9. 6.2.2 Teva Business Overview
  10. 6.2.3 Teva Consumer Healthcare Drug Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Teva Consumer Healthcare Drug Product Portfolio
  12. 6.2.5 Teva Recent Developments
  13. 6.3 Shanghai Pharmaceuticals
  14. 6.3.1 Shanghai Pharmaceuticals Company Information
  15. 6.3.2 Shanghai Pharmaceuticals Business Overview
  16. 6.3.3 Shanghai Pharmaceuticals Consumer Healthcare Drug Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Shanghai Pharmaceuticals Consumer Healthcare Drug Product Portfolio
  18. 6.3.5 Shanghai Pharmaceuticals Recent Developments
  19. 6.4 Sanofi
  20. 6.4.1 Sanofi Company Information
  21. 6.4.2 Sanofi Business Overview
  22. 6.4.3 Sanofi Consumer Healthcare Drug Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Sanofi Consumer Healthcare Drug Product Portfolio
  24. 6.4.5 Sanofi Recent Developments
  25. 6.5 Johnson & Johnson
  26. 6.5.1 Johnson & Johnson Company Information
  27. 6.5.2 Johnson & Johnson Business Overview
  28. 6.5.3 Johnson & Johnson Consumer Healthcare Drug Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Johnson & Johnson Consumer Healthcare Drug Product Portfolio
  30. 6.5.5 Johnson & Johnson Recent Developments
  31. 6.6 Merck & Co.
  32. 6.6.1 Merck & Co. Company Information
  33. 6.6.2 Merck & Co. Business Overview
  34. 6.6.3 Merck & Co. Consumer Healthcare Drug Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Merck & Co. Consumer Healthcare Drug Product Portfolio
  36. 6.6.5 Merck & Co. Recent Developments
  37. 6.7 Pfizer
  38. 6.7.1 Pfizer Company Information
  39. 6.7.2 Pfizer Business Overview
  40. 6.7.3 Pfizer Consumer Healthcare Drug Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Pfizer Consumer Healthcare Drug Product Portfolio
  42. 6.7.5 Pfizer Recent Developments
  43. 6.8 Hualan Bio
  44. 6.8.1 Hualan Bio Company Information
  45. 6.8.2 Hualan Bio Business Overview
  46. 6.8.3 Hualan Bio Consumer Healthcare Drug Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Hualan Bio Consumer Healthcare Drug Product Portfolio
  48. 6.8.5 Hualan Bio Recent Developments
  49. 6.9 North China Pharmaceutical
  50. 6.9.1 North China Pharmaceutical Company Information
  51. 6.9.2 North China Pharmaceutical Business Overview
  52. 6.9.3 North China Pharmaceutical Consumer Healthcare Drug Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 North China Pharmaceutical Consumer Healthcare Drug Product Portfolio
  54. 6.9.5 North China Pharmaceutical Recent Developments
  55. 6.10 Hengrui Medicine
  56. 6.10.1 Hengrui Medicine Company Information
  57. 6.10.2 Hengrui Medicine Business Overview
  58. 6.10.3 Hengrui Medicine Consumer Healthcare Drug Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Hengrui Medicine Consumer Healthcare Drug Product Portfolio
  60. 6.10.5 Hengrui Medicine Recent Developments
  61. 6.11 GlaxoSmithKline
  62. 6.11.1 GlaxoSmithKline Company Information
  63. 6.11.2 GlaxoSmithKline Business Overview
  64. 6.11.3 GlaxoSmithKline Consumer Healthcare Drug Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 GlaxoSmithKline Consumer Healthcare Drug Product Portfolio
  66. 6.11.5 GlaxoSmithKline Recent Developments
  67. 6.12 Bayer
  68. 6.12.1 Bayer Company Information
  69. 6.12.2 Bayer Business Overview
  70. 6.12.3 Bayer Consumer Healthcare Drug Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Bayer Consumer Healthcare Drug Product Portfolio
  72. 6.12.5 Bayer Recent Developments
  73. 6.13 AbbVie
  74. 6.13.1 AbbVie Company Information
  75. 6.13.2 AbbVie Business Overview
  76. 6.13.3 AbbVie Consumer Healthcare Drug Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 AbbVie Consumer Healthcare Drug Product Portfolio
  78. 6.13.5 AbbVie Recent Developments
  79. 6.14 Sinopharm Group
  80. 6.14.1 Sinopharm Group Company Information
  81. 6.14.2 Sinopharm Group Business Overview
  82. 6.14.3 Sinopharm Group Consumer Healthcare Drug Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Sinopharm Group Consumer Healthcare Drug Product Portfolio
  84. 6.14.5 Sinopharm Group Recent Developments
  85. 6.15 Livzon Group
  86. 6.15.1 Livzon Group Company Information
  87. 6.15.2 Livzon Group Business Overview
  88. 6.15.3 Livzon Group Consumer Healthcare Drug Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 Livzon Group Consumer Healthcare Drug Product Portfolio
  90. 6.15.5 Livzon Group Recent Developments
  91. 6.16 Fosun Pharma
  92. 6.16.1 Fosun Pharma Company Information
  93. 6.16.2 Fosun Pharma Business Overview
  94. 6.16.3 Fosun Pharma Consumer Healthcare Drug Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 Fosun Pharma Consumer Healthcare Drug Product Portfolio
  96. 6.16.5 Fosun Pharma Recent Developments
  97. 6.17 East China Medicine
  98. 6.17.1 East China Medicine Company Information
  99. 6.17.2 East China Medicine Business Overview
  100. 6.17.3 East China Medicine Consumer Healthcare Drug Revenue, Global Share and Gross Margin (2021-2026)
  101. 6.17.4 East China Medicine Consumer Healthcare Drug Product Portfolio
  102. 6.17.5 East China Medicine Recent Developments
  103. 6.18 CR Pharmaceutical
  104. 6.18.1 CR Pharmaceutical Company Information
  105. 6.18.2 CR Pharmaceutical Business Overview
  106. 6.18.3 CR Pharmaceutical Consumer Healthcare Drug Revenue, Global Share and Gross Margin (2021-2026)
  107. 6.18.4 CR Pharmaceutical Consumer Healthcare Drug Product Portfolio
  108. 6.18.5 CR Pharmaceutical Recent Developments
7 North America
  1. 7.1 North America Consumer Healthcare Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Consumer Healthcare Drug Market Size by Country (2021-2026)
  3. 7.3 North America Consumer Healthcare Drug Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Consumer Healthcare Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Consumer Healthcare Drug Market Size by Country (2021-2026)
  3. 8.3 Europe Consumer Healthcare Drug Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Consumer Healthcare Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Consumer Healthcare Drug Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Consumer Healthcare Drug Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Consumer Healthcare Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Consumer Healthcare Drug Market Size by Country (2021-2026)
  3. 10.3 South America Consumer Healthcare Drug Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Consumer Healthcare Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Consumer Healthcare Drug Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Consumer Healthcare Drug Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst